MENU

PARA SA MGA DOCTOR

A. When to refer to a nephrologist?

  • Persistent proteinuria (+2)
  • Persistent hematuria
  • Recurrent UTI / persistent pyuria
  • Serum Creatinine > 1.5 mg/dL
  • Uncontrolled BP (>150/90) despite 4 agents at therapeutic doses in a patient with CKD
  • Suspicion of renal involvement from a systemic illness
  • Recurrent or extensive nephrolithiasis
  • “The earlier you refer your patients, the earlier we can treat them and avoid / delay need for renal replacement therapy or halt progression of kidney disease. Once patient’s condition is stable / improved, we will refer them back to you.”

B. Valuable information to send with referral

  • Brief general medical history
  • Medication history
  • Physical examination
  • All available laboratories / imaging

C. You can contact our department anytime for questions about your case, just call 981-0368 and look for the on-duty Adult Nephrology fellow

PARA SA MGA PASYENTE

A. Sino ang pwedeng mag-karoon ng sakit sa bato?

  • Kahit sino ay maaaring magkasakit sa bato, bata man o matanda kaya huwag ipagsawalang bahala ang mga nararamdaman

B. Ano ang mga kundisyon na nakakapinsala sa ating bato?

  • Diabetes dahil sa sobrang asukal sa dugo, nahihirapan ang bato na salain ito
  • Hypertension dahil sa pagkasira ng mga daluyan ng dugo sa katawan kasama na ang ugat sa bato
  • Sakit sa puso
  • Pag-inom ng mga gamot para sa kirot (non-steroidal anti-inflammatory drugs)
  • Pag-inom ng mga gamut na nagmumula sa mga halaman (herbal medications)
  • Paninigarilyo
  • Pagbigat ng timbang na higit pa sa naaayon sa tangkad
  • Pagkakaroon ng kamag-anak na may sakit sa bato
  • Pagkakaroon ng mga bato na maaaring bumara sa daluyan ng ihi
  • Pamamaga ng ugat sa bato na maaaring nakuha sa impeksiyon sa lalamunan o balat
  • Pagkakaroon ng impeksiyon o pamamaga ng daluyan ng ihi at pagdami ng mga organismo o mikrobyo sa bato at sa pantog

C. Ano ang mga sintomas ng sakit sa bato?

  • Maaaring walang nararamdaman ang taong may sakit sa bato
  • Pagmamanas ng paa, mukha o buong katawan
  • Mabulang ihi
  • Ihi na kulay tsaa
  • Pag-ihi ng madalas (> 3 beses) sa gabi

D. Ano ang mga sintomas kapag malala na ang sakit sa bato?

  • Pagkonti o pagkawala ng ihi
  • Hirap sa pag-hinga
  • Pag-sakit ng tyan
  • Walang gana kumain
  • Pagkahilo at pagsusuka
  • Hirap sa pagtulog
  • Pangangati sa buong katawan

E. Ano ang dapat masuri para malaman kung may sakit sa bato?

  • Ihi (Urinalysis)
  • Dugo (Creatinine)

F. Paano maiiwasan ang sakit sa bato?

  • Panatiliing normal ang asukal sa dugo (fasting blood sugar < 140 mg/dL)
  • Panatiliing mababa ang blood pressure (BP < 140/90 mmHg)
  • Uminom ng madaming tubig (2-3 litro kada araw)
  • Kumain ng tama at hindi labis
  • Umiwas sa sobrang maaalat na pagkain tulod ng mga sawsawan na patis at toyo
  • Huwag uminom ng labis na alcohol
  • Tumigil sa paninigarilyo
  • Regular na ehersisyo
  • Huwag iinom ng gamot / herbal ng walang payo ng doktor
  • Regular na magkonsulta sa doktor

G. Paano ginagamot ang sakit sa bato?

  • Magkonsulta sa isang doctor na espesyalista sa bato (Nephrologist)
  • Maaring komunsulta sa “Preventive Nephrology Clinic” sa NKTI OPD tuwing Lunes, Martes at Biyernes, 9 – 10 AM

H. Other resources available (contact secretary for details):

  • Handbook for kidney transplant recipient
  • Handbook for kidney transplant donor

EMPHYSEMATOUS PYELONEPHRITIS by Edmundo Pasamba, M.D

CRBSI by Edmundo Pasamba, M.D

CARDIORENAL SYNDROME by Edmundo Pasamba, M.D

GLUCOSE CONTROL IN RENAL TRANSPLANT by Melody Atienza-Peña, M.D

PNEUMONIA IN TRANSPLANT PATIENTS by Luis Limchiu, M.D

ELDERLY AND DIURETICS by Luis Limchiu, M.D 

AKI RHABDOMYOLYSIS by Fiona Javelosa-Tan M.D

  

News and Updates

NKTI Department of Adult Nephrology recently launched Preventive Nephrology Clinic last June 17, 2017. This program aims to provide comprehensive management plan for persons identified with risk factors (e.g. hypertension, diabetes, relatives with CKD) and those with early signs of renal disease. This simple initiative hopes to create a ripple of positive effects in the long run, in decreasing the number of patients who will end up in dialysis in the future.

Preventive Nephrology Clinic
National Kidney and Transplant Institute - OPD Clinic
Monday, Tuesday and Friday
10:00 AM – 12:00 PM

 

 

About Us

The NKTI Cardiovascular Catheterization and Radiology Unit is a highly specialized facility that provides valuable still and motion x-ray pictures (fluoroscopy) of the arteries used in detecting abnormalities of the heart and providing interventional procedures as needed by the patient. The Unit utilizes a multi-disciplinary approach to perform cardiovascular, endovascular and radiology interventions throughout the body and certain surgical procedures.


Services

The Unit is divided into 3 services namely Interventional Cardiology, Vascular and Peripheral Intervention and Interventional Radiology. The Unit performs the following procedures:

Interventional Cardiology

  • Coronary Angiography
  • Percutaneous Transluminal Coronary Angioplasty (PTCA)
  • Temporary & Permanent Pacemaker Insertion
  • Implantable Automated Cardioverter and Defibrillator (IACD)
  • Valvuloplasty
  • Pericardiocentesis
  • Hemodynamic Study
  • Intra-aortic Balloon Pump Insertion

Interventional Radiology

  • Trans-Arterial Chemo Embolization (TACE)
  • Cerebral Angiography
  • Gastrointestinal and Bronchial Embolization

Peripheral and Vascular Intervention

  • Peripheral Venogram / Venoplasty of Upper & Lower Extremities
  • Peripheral Venogram / Venoplasty of Upper & Lower Extremities with Stenting
  • Peripheral Angiogram / Angioplasty of Upper & Lower Extremities
  • Peripheral Angiogram / Angioplasty of Upper & Lower Extremities with Stenting
  • Carotid and Renal Angiogram / Angioplasty
  • Carotid and Renal Angiogram / Angioplasty with Stenting
  • Renal Graft Stenting
  • IVC Filter Insertion
  • Endovascular Repair of Aneurysm (EVAR)
  • Thoraco-Vascular Repair of Aneurysm (TVAR).
  • Fluoro-Guided Temporary and Permanent Catheter Insertion (Hemo Access)

Our Expert Team

Section Head: Dr. Rogelio V. Tangco, MD
Interventional Cardiologist:

Dr. Carlo John M. Manalo, MD
Dr. Dodee Niño V. Rigor, MD
Dr. Albert Jerome B. Geronimo, MD
Dr. Roy E. Garrido, MD
Dr. Romeo G. Molano, Jr, MD

Interventional Cardiologist-Eletrophysiologist:

Dr. Clara S. Tolentino, MD
Dr. Peter Carlo M. Nierras, MD
Dr. Michael- Joseph F. Agbayani, MD
Dr. Erdie C. Fadreguilan, MD

Interventional Radiologist:

Dr. Orlando R. Ignacio, MD
Dr. Ferdinand L. Morabe, MD
Dr. Glenn Marc G. Ignacio, MD
Dr. Gerardo M. Silva, MD
Dr. Renato M. Castro, MD

Interventional Vascular Surgeon:

Dr. Ricardo DT. Quintos, MD
Dr.  Leo Carlo V. Baloloy, MD
Dr. Rainan G. Gloria, MD


Contact Us

Mailing Address:

2nd Floor, Diagnostic Center
National Kidney and Transplant Institute
East Avenue, Quezon City 1100

Email Address: cathlab@nkti.gov.ph

Contact Numbers: (63) (2) 8981-0300, 8981-0400 loc 2414

PET/CT Center Services Patient preparationMedical expert team | Contact us


Hybrid 18FDG-positron emission tomography and computed tomography (18FDG -PET/CT) is an indispensable imaging modality in the fields of neurology, cardiology, infection/ inflammation and most especially, oncology. Cancer cells have increased metabolic activity and generally have increased glucose uptake. 18FDG-PET/CT detects abnormal glucose metabolism within the body. Primary malignant lesion and local and distant metastases would usually show increased 18FDG tracer uptake on PET/CT images.

Note to referring physician: The CT component of PET/CT camera helps in correcting artifacts on PET images and provide more accurate anatomic localization. Outside diagnostic CT scans (from other institutions) can also be combined with the PET images. The use of IV CT contrast is not recommended in order to prevent image artifacts, potential allergic reactions and risk of nephrotoxicity.

NKTI PET/CT Center Services:

1. Oncologic indications for 18FDG -PET/CT scan:

  • Initial staging of disease
(Lung cancer patient)
  • Treatment response monitoring
    (Patient A: Hodgkin’s lymphoma post-chemotherapy)

(Patient B: Hodgkin’s lymphoma post-chemotherapy)
  • Re-staging of disease
(Primary biliary carcinoma after surgery and chemotherapy)
(uterine sarcoma post-surgery)
  • Radiotherapy planning
(radiotheraphy planning: left  and right side)
  • Evaluation of unknown primary malignancies
(unknown primary malignancies)

(Studies have shown effectiveness of 18FDG -PET/CT scan in the up-staging or down-staging of cancer, leading to change of treatment. Residual and recurrent cancer lesions can also be differentiated from post-radiation and post-surgical changes. A second or even third concurrent primary malignancy may also be detected.)

2. 18F-choline PET-CT: Single step, whole body and non-invasive. Allows localization of cancer and loco-regional metastases.  Accurately evaluates Prostate Cancer.

Prostate Carcinoma: Life Threatening Cancer Affecting Men

The major goals of pre-therapeutic imaging are to determine the local extent of prostate carcinoma in terms of:

  • Intra-prostate localization
  • extracapsular extension
  • seminal vesicle invasion
  • tumor infiltration into neurovascular bundles, surrounding tissues and organs in the small pelvis
  • detection of loco-regional metastases via the lymph nodes
  • detection of distant metastases

Key Challenges

Both anatomic and functional molecular imaging of prostate carcinoma are important when there are problems in diagnosis, such as when prostate punch biopsies are negative, while suspicion of prostate carcinoma persists.

Not all tumors show significant increase of metabolic activity with 18F-FDG PET/CT as seen in neuroendocrine tumors, hepatic tumors and prostate cancer.

Choline presents high affinity for malignant prostate tissue, even if low grade.  18F-choline PET/CT is highly sensitive and accurate in staging and restaging prostate cancer pre-operatively and after treatment.

18F-choline PET/C is a useful imaging modality in such patients.  It is highly efficient in preoperative management and staging of cancer once metastatic disease is strongly suspected.

Indications for 18F-choline PET/CT

In the evaluation of patients with prostate cancer, it covers a wide spectrum of clinical settings:

  • Localization of intra-prostatic neoplastic lesions
  • Initial staging
  • Detection of occult metastases
  • Characterization of images on conventional imaging modalities

Sensitive. Specific. Accurate.

18F-choline PET/CT may be superior to bone scintigraphy for the early detection of metastatic bone disease due to the detection of bone marrow metastases.

Localization of recurrent prostate cancer is critical for selecting a local or systemic therapeutic strategy.
18F-choline PET/CT augments the diagnostic imaging spectrum for the assessment of relapsing prostate cancer.

It is useful in demonstrating the spread of disease preoperatively and to detect local recurrent disease after radical prostatectomy or radiation therapy.

18F-choline PET/CT is also useful for the evaluation of other cancers such as hepatocellular carcinoma.

Optimizing 18F-Choline PET/CT for Patients

  • Gives relevant impact on patient management.
  • Allows the distinction between patients treatable with local radiation therapy, from those with distant spread in whom systemic therapy was planned.
  • Provides good quality imaging to visualize recurrent disease.
  • Avoids false-positive results related to urinary excretion.
  • 18F-choline PET/CT allows early localization of recurrent prostate carcinoma.

Patient Preparation Instructions Before 18F-Choline PET/CT Procedure

  1. Abstain from food 6hrs prior to the procedure.
    Only water intake during the fasting period.
  2. If sedated, NO FOOD or WATER, 8-hrs fasting time.
  3. If diabetic, fasting time is 4hrs. Eat a full meal before fasting.  Do not inject insulin during the fasting period.
  4. Maintenance medications can be taken during the fasting period.
  5. Bring pervious medical results such as CT Scan, MRI, PET/CT Scan including films and flash drive; tumor markers, biopsy reports and lab results.
  6. Come in comfortable clothes without buttons, zippers and metallic objects.
  7. Inform us of food allergies or medications or if you feel ill and wish to defer the procedure, at least a day prior to your PET/CT scan.
  8. Please bring the latest creatinine result done within the month of your scheduled date. This is needed prior to your schedule.

Role of 18F-choline PET/CT  in evaluation of patients with prostate carcinoma. Research Article. Hodolic, Marina. Radio Onco. 2011. Optimising 18F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients. Massaro, et.al. N Am J Med Sci. 2012

  • 18F-Choline PET/CT for Prostate Cancer = P65,000

3. Neurologic indications for 18FDG -PET/CT scan:

  • Aid in diagnosis and treatment response of dementia disorders (Alzheimer’s, Parkinson’s etc. )
  • Aid in localization and treatment response of epilepsy disorders (post-ictal stage)

NKTI PET/CT Center’s introductory price: until end of 2015/ first 100 patients

  • 18FDG -PET/CT for oncology purposes:
    (regular price of Php 65,000)  Php 49,900
  • 18FDG -PET/CT for brain imaging:
    (regular price of Php 55,000)  Php 39,900

Patient preparation 

  • At least 6 hours of fasting, water intake is allowed
  • Refrain from strenuous physical activity (e.g. exercise) for 48 hours prior to the scan
  • Inform staff if you have diabetes/ pregnant/ breastfeeding
  • Inform staff of maintenance medications beforehand
  • Bring all recent (within 6 months) x-ray, CT and/ or MRI films or digital format (CD/DVD/ USB)
  • Please have a companion with you.

What to expect during day of the scan

  • The whole procedure takes about 3-4 hours to complete. The actual scan duration is approximately 45-60 minutes, depending on the patient’s height and body built. Non-oncological indication would take a shorter time.
    • You will be asked to change into a hospital gown
    • 18FDG tracer would be given intravenously (IV injection). No allergy cases and side effects have been reported.
    • Post-tracer injection, you will be asked to sit still or lie down for approximately 60 minutes. Talking, chewing/ eating, strenuous activity is discouraged during the waiting time before the scan.

Is PET/ CT Safe? 

The 18FDG radio tracer used at NKTI has been certified to be of excellent quality based on local and international standards (FDA LOT No. CDRR-NCR-DM-348). 

A patient receives about 7mSv of radiation from a PET study alone. At NKTI, the CT component is optimized to minimize additional radiation to the patient while maintaining image quality. About 5 mSv is added from the CT part, hence a total of 12 mSv received from the PET/CT scan procedure. High-dose diagnostic CT would send a total of 20 mSv to the patient. The general population receives about 1 mSv of natural background radiation a year (e.g. from sunlight). 


After the scan

  • No side effects.
  • Drink water frequently to hasten radio tracer removal from the body.
  • Regular diet can be resumed.
  • Results available after two working days. Your doctor will interpret the PET/CT scan results for you. 

Medical expert team

Co-Heads: Dr. Angelo O. Martinez and Dr. Gerardo M. Silva

PET Consultants:

Dr. Jamilla Cecilia L. Gomez
Dr. Joel C. Mendoza

CT Consultants:

Dr. Rosanna E. Fragante
Dr. Rene D. Bautista
PET CT Manager Bryan Cyril Jacalne
PET CT Nurses

Bernice Abigael Advincula
Juof Michael Salvilla
Jamy Rae Agustin
Jaidee Baldos

PET CT Technologist: Paul Pontilan
Michelle Anne Marquez
Ryan Jefferson Florentino
PET CT Receptionist Divinah Arguelles
Damsel Daffodil Lorenzo
Physicist Joselito Dela Cruz

 Contact us

PET/CT Section
Ground floor, Diagnostic Centre, NKTI
East Avenue, Diliman, Quezon City
Operating Hours:
Monday-Friday 7:00 am to 6:00 pm
Tel. no. (63) (2) 8981-0300, 8981-0400 local 1445, 1446 / Tel. no. 282-38-79
Mobile no. 0917-3297-812 / 0998-9507-051
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

The Gender and Development Focal Point System (GFPS) of National Kidney and Transplant Institute was established in February 2014. Its purpose is catalyze and accelerate gender mainstreaming across the organization to ensure that in its development there in equality in the participation and empowerment of its people towards an effective implementation at strategies for equality services to its clienteles.


VISION

The NKTI GFPS strives to achieve quality services on patient care, training and research through gender responsive governance.


MISSION

Support the NKTI’s thrust through mainstreaming gender and development in all its programs and operations.
Promote gender equality and provide gender sensitive services among stakeholders.

CORE VALUES Core values translated in Filipino
Gender - sensitivity Pagkakapantay-pantay ng ating kapwa
Empowerment Pagpapalawig ng kakayahan
Nondiscriminatory Patas ng pakikitungo
Dignity Pagpapahalaga sa dangal pantao
Empathy Pag-agapay
Respect Paggalang

QUALITY OBJECTIVES

  • Mainstream gender and development in all NKTI offices
  • Establish a mechanism for gender – responsive policy and program formulation and implementation.
  • Build data management system as means for tracking gender.


GFPS Organizational Structure


GENDER SPECIFIC & REPRODUCTIVE HEALTH AND WELLNESS

Aiming to give its patients a better quality of life, the National Kidney and Transplant Institute provides gynecology services to its female patients to monitor certain reproductive health conditions prior to transplantation. The Women’s Health Clinic, on the other hand, meets the needs of female non-transplant patients. The Clinic offers the following services:

OUT-PATIENTS

  • Consults
  • Cervical screening with conventional Pap Smear
  • HPV Vaccination
  • OB-GYN ultrasound
  • Colposcopy of the vulva, vagina, cervix
  • Infertility work-ups
  • Gynecologic clearances for female patients who will undergo kidney transplant and donor nephrectomy
  • Office procedures including cervical and endometrial biopsies
  • Day surgeries at the minor operating room (e.g., curettages, excision and cautery)

IN-PATIENTS

  • Surgery for benign gynecologic conditions
  • Surgery for malignant gynecologic conditions
  • Minimally invasive surgery for both benign and malignant gynecologic conditions
  • Interdepartmental referrals
  • Participation in cases needing multidisciplinary care
  • Part of the executive check-up

Since men are women’s partners in the act of nation-building, specific health programs have been created for men. The Center of Urology and Men’s health (CUMH) offers services like Urology, Oncology, Lithotripsy, Neuro-Urology and Urodynamics, Male Infertility and Andrology.

The Gender Specific and Reproductive Health and Wellness Program for men and women was launched in January 2016 through the Institute’s Lifestyle Medicine Program.

Merika D. Jimenez
Chairperson, NKTI-GFPS-TWG



BLOOD ASSAYS

Thyroglobulin

Method: Thyroglobulin - Immunoradiometric assay (IRMA)

Specimen: Thyroglobulin - serum

Receiving specimen (Date): Monday to Friday

Processing/ running days: Thursday

Cut-off time: 9AM

Release of Results: 1 to 2 working days

Clinical significance: Thyroglobulin is a protein produced by both normal and cancerous thyroid cells. After treatment of thyroid cancer, serum thyroglobulin is useful as a tumor marker for monitoring and routine surveillance.


Anti-Thyroglobulin Ab

Method: Anti-Thyroglobulin- Radioimmunoassay (RIA)

Specimen: Anti-Thyroglobulin- serum

Receiving specimen (Date): Monday to Friday

Processing/ running days: Thursday

Cut-off time: 9AM

Release of Results: 1 to 2 working days

Clinical significance: Anti-Thyroglobulin antibody (anti-Tg) is helpful for diagnosis of autoimmune thyroid disorders. This is also particularly useful in monitoring patients treated for differentiated thyroid cancer. The presence of anti-Tg (which occurs in 15% to 30% of thyroid cancer patients) could result in artifactually high or low Thyroglobulin results.

GENERAL REQUIREMENTS:

  1. Updated PRC License
  2. Current Intravenous Therapy Card
  3. Basic Life Support (BLS)/ Advanced Cardiac Life Support (ACLS) Card or Certificate
  4. Philippine Nurses’ Association Membership Card
  5. Medical: Hepatitis B Surface Antigen Screening; if nonreactive, Anti-HbS Screening and Certificate of Hepatitis B vaccination; and Chest X-ray (within 6 months prior to practicum)
  6. (1) 1x1, 2x2 pictures

Note: Requirement #1-4 please photocopy; bring original for validation

Courses Offered

Requirements

Registration Fee

Duration

Competency Development in Basic Nephrology Nursing

GENERAL REQUIREMENTS only

15,000

4 mos

Competency Development in Peritoneal Dialysis

GENERAL REQUIREMENTS

Must have Certificate of Proficiency if Basic Nephrology Nursing graduate or Certificate of bedside experience of at least 6 months as a staff nurse in a 150-bed capacity hospital

Renal Nurses Association Membership Card

 

 

 

 

 

 



12,000

2 mos

Competency Development in Hemodialysis

22,000

4 mos

Competency Development in Kidney Transplantation

12,000

2 mos

Competency Development in Operating Room Nursing

22,000

4 mos

Proficiency Training in Emergency Care Nursing (ER)

3,000

1 month

Proficiency Training in Critical Care Nursing (ICU)

3,000

1 month

REGISTRATION: Monday to Friday, 8AM-5PM, IANAHP Office, 3rd Floor, Diagnostic Center Building, National Kidney and Transplant Institute

For Inquiries: Office – 89810400 local 3469, Telefax – 89243601 local 1133, Email- This email address is being protected from spambots. You need JavaScript enabled to view it.


I have been fortunate to assume the role as the 6th Executive Director of NKTI. We are now reaping all the labor, hard work, and pain of our predecessors. I
am very enthusiastic to face the challenges in sustaining the growth of NKTI as it has evolved over the years stronger, competitive, and progressive. As the NKTI
has already matured physically and internally, we are encouraged to work together in order to continue our legacy by indoctrinating new breeds of professionals
that shall lead the Institute in the future.

We are very grateful to our partners who have been supporting NKTI over the years and enabling us to deliver the services needed by our patients. We thank our Board of Trustees and the NKTI Officers and Employees as instruments in the fulfillment of our vision.

As NKTI continues its role of being one of the country’s premier specialty hospitals, the present management strengthened its resolve and focuses its directions
towards the mandate of the Department of Health – “Daang Matuwid para sa Kalusugang Pangkalahatan” (“A Straight Path for Universal Healthcare”).

Guided by the direction of former Executive Director and now Secretary of Health of the Philippines, Dr. Enrique T. Ona, the NKTI as the leading tertiary specialty
hospital for nephrology, urology, vascular, and organ transplantation will further strengthen the Philippine government’s position in providing health care services
to the nation irregardless of social and economic status.


The End of the Land Dispute

Thirty years ago, we have always been restricted to expand our physical structure because of our legendary land dispute with the National Housing Authority  (NHA). We are now in the process of securing the land title as we have already paid for the two parcels of the unoccupied land area from the NHA through the intervention and financial support of the National Government. Said land dispute has been a long-standing battle dating back to Dr. Claver Ramos’ administration in the late 80’s. In securing our primary asset, we can now push forward more expansion of our facilities to further enhance our patient-care services.


Maintaining and Sustaining Operational Efficiency

With the expanded Philippine Health Insurance Corporation (Philhealth) coverage especially for kidney transplant (Z Package), the NKTI has opened the new
Philhealth ward. We had a 5-bed addition to our existing 310 bed capacity which aims to provide immediate accommodation services to the increasing number of
Philhealth members.

On its 30th year, the NKTI was able to maintain and sustain its expertise. The volume of our service coverage would reflect the level of our performance. The significant growth in hospital services has been aggressive in terms of facility enhancement through expansion, renovation, and equipment acquisition.

In assessing our worth being a government instrumentality, our commitment to service and social development has been proven and strengthened through
our increasing number of out-patient services. We have recorded 42,500 out-patient consultations per year compared to 28,500 consults/year 10 years ago. The in-patient service on the other hand continues to rise due to the increase in bed capacity. We are presently accommodating a total of 15,500 patient admission per year compared to 10,000 in 2003.

Amidst the post-implementation effect of regulatory policies in organ transplantation that led to the significant decrease in the number of kidney transplantations dropping to an average of 275 cases in the last 3 years compared to 347 in 2006 - 2009, the Institute was able to increase the deceased organ donor referrals through strengthening its organ procurement program, the Human Organ Preservation Effort (HOPE). The cadaveric program has contributed a 16% increase in the total kidney transplantation done in 2013 i.e. 64 harvested kidneys vs. 48 in 2012; they conducted 27 advocacy seminars to various medical institutions in NCR and nearby provinces which resulted in 150 received referrals.

The Hemodialysis Center has catered to 45,523 patients (45,465 in 2012). The center recorded an average increase of 8% per year and nearly reaching its peak in terms of number of treatments that can be delivered by the existing 43 hemodialysis machines operating at a fixed number of shifts (24/7). The management is now planning to expand the hemodialysis facility in the next 2 to 3 years in order to align the Institute to increasing demands.

The Center for Urology and Men’s Health (CUMH) and Operating Room Expansion Project is expected to be completed by the 2nd quarter of 2014. The CUMH
is another addition to the service commitment of the Institute by intensifying its urological services for men and women. It is envisioned to become the  national referral center that will house the latest equipment with highly skilled urologists.

The Main Signage at the NKTI gate was reconstructed to provide a fitting and welcoming atmosphere to all types of clients. Also, the signage improvement was part of the organizational advertisement aimed to reach external clientele by imposing heath care expertise and commitment to quality service of the NKTI. Alongside with the new NKTI Main Signage, was the construction of the covered walkway planned not for aesthetic reasons alone but primarily for providing service to patients and employees in terms of safety especially during inclement weather and promoting wellness.


 

As an Instrument of Change

The NKTI has entered into another remarkable project, the acquisition of the Positron Emission Tomography and Computerized Tomography Scan and a  Cyclotron Equipment, through a lease contract agreement (a variant of the Public-Private Partnership). The first for government hospitals, the NKTI again will
bridge the gap in health services through the delivery of high-end level diagnostics and treatment to the general populace. This effort is towards enhancing the offered services to numerous patients afflicted with cancer especially in government medical institutions. A PET-CT machine is well-known to have an extensive diagnostic capacity that provides complete information on cancer localization and surveillance. On the other hand, the Cyclotron Manufacturing Facility shall ensure a secured supply of radiopharmaceutical – a vital requirement (fluorodexyglucose or FDG) –needed to detect the increase in metabolism found in cancers.

We have been actively cooperating with the DOH who entrusted to the NKTI the task of procuring modern and sophisticated machines and equipment to be allocated to different DOH Hospitals and local government health facilities nationwide. The NKTI – Special Bids and Awards Committee (SBAC) has been  formulated and was composed of the Institute’s key employees from various fields. In 2013 alone, the NKTI-SBAC was able to save close to PhP 685 Million.

The Philhealth has recently launched and mobilized its Z Benefit Packages for Catastrophic Cases and the NKTI has been chosen as a reference hospital for the package in providing financial support for the hospitalization of Philhealth members. The NKTI was tasked to spearhead the flagship program covering the packages for prostate cancer and kidney transplantation. In its first year, the Institute has already accommodated 10 patients with prostate cancer and 77 kidney transplantation.

It is expected that for the years to come, numbers will double as Philhealth will expand its effort in promoting Z package towards full attainment of universal health care.


 

Financial Capacity Highlights

The financial viability of the NKTI remains strong and positive amidst the effects of external regulatory bodies. We have been able to sustain and increase our retained earnings amounting to PhP 3,557 Million. Due to the higher utilization of our cost centers, the Institute’s gross revenue increased by 5%. On the other hand, the cost of Quantified Free Service (QFS) extended to our service / indigent patients has increased by 6% while the subsidy to the total  corporate operating budget coming from the national government is only 9% in 2013.

The financial capacity of the institution was put to test when the Priority Development Assistance Fund (PDAF) of legislators was abolished in the 2nd half of
2013. The development impact of the PDAF has attested its significance as it became the primary instrument (financial support) of the politicians to indigent patients and their constituents for access to health care services. Amidst the increasing numbers of patient referrals, the NKTI over the years has prove its commitment not only for being their “hospital of choice” but also by rendering unbiased health care services to the Filipino people coming from all walks of life.


 

Operational Development and Human Resources

The reassignment and rotation of personnel has been very usual this year. Together with the Director of Administrative Services, Dr. Zenaida L. Antonio, the management is continuously looking at the best possible fit for every employee. The primary objective is to provide a niche where our employees can “go,  grow, and glow”.

The medical and surgical departments are considered to be the key performance players of the institution; they were given the autonomy to develop in terms of technical capacity and professional growth. The management has been very cooperative with their technical needs such as providing them top-of-the-line
medical equipment, tools, and infrastructure where they can practice and enhance their skills such as the operating room expansion project, which will house
the nations’ first modular operating room that shall complement the high-end training needs of medical and paramedical staff. We started to invest in skills
development training by sending a group of doctors to train abroad in line with the thrust of reviving the liver transplant unit of the NKTI.

The Nursing Service Office being the frontline patient care provider has led various initiatives in research and process improvement towards improving quality
outcomes and reduction of patient-related incidents. One of the highlights of their continuing commitment is the implementation of the E3N Program (Efficient, Effective, and Equitable), which includes monitoring of the common types of patient-related incidents, evaluation, improving the communication lines, and reducing the turn-around time in addressing corrective measures. This effort is in line to the quality objectives of the Institute towards making NKTI an error-free and patient-friendly institution.


 

Commitment to our Social Contract

Year 2013 has brought intense natural disasters in the Philippines, such as the “habagat” and typhoon Yolanda. These were unfortunate events that  devastated the lives of our fellow countrymen both physical and emotional. As a specialty center, we have been an active player in providing immediate care due to the aftermath of the flooding and typhoon especially during the leptospirosis outbreak when we became the lead referral center for its complications – particularly renal failure. Our years of experience in calamity response have enabled us to develop our own operations manual for leptospirosis outbreaks. The manual has been recognized by the DOH and has been adapted by various government hospitals as part of their emergency preparedness program.

As part of the Health Emergency Management System, we were able to provide full support to the DOH by sending some our paramedical and medical staff to aide our fellow countrymen devastated by super typhoon “Yolanda”. The NKTI has been able to generate enough goods that were donated to Tabango City
Hospital in Shamrock Leyte. The donated cash by our doctors will be used next year for the medical mission as the management is planning to adopt a medical facility and convert it to a satellite hospital that will provide our expertise in the field of nephrology, urology, and vascular surgery.

On its 31st year of existence and as the 6th torch bearer of the NKTI, it is indeed a great challenge when we talk about institutional legacy and service  continuity. Our primary aim is not only to continue what was done before but also on how the Institute will holistically grow by embracing change and  confronting challenges.

Let us all look enthusiastically and positively onwards to 2014 and beyond.

nkti.gov.ph feed

feed-image Feed Entries